Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsNA

Investigating the Effects of Transcranial Stimulation to Advance Stroke Rehabilitation

Sponsor: University of Oxford

NCT ID: NCT06842095

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Access to the study treatment being tested
Type of study
Interventional (receives a drug or procedure)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Transcranial Alternating Current Stimulation (beta-tACS) (other), Transcranial Alternating Current Stimulation (sham) (other)
How long the study runs
Study runs about 24 months (dates as stated)
About the drug or intervention
Transcranial Alternating Current Stimulation (beta-tACS) — other: The study intervention is transcranial alternating current stimulation (tACS). · Transcranial Alternating Current Stimulation (sham) — other: The comparator is sham stimulation.
Patient visit burden
Not specified by the sponsor
Type of study
Testing a treatment
Ages
18 Years and over
Who
All
Number of participants
60
Started
2025-02-01
Last checked
2024-07

Plain English Summary

What is this study?

  • • Testing a new treatment for stroke
  • • NA - 60 participants
  • • Non-invasive brain stimulation (NIBS) has the potential to boost rehabilitation after stroke by creating a 'pro-plastic' environment, where the brain is more adaptable in response to movement (motor) training

Who can take part?

  • • Ages 18 Years and over
  • • Diagnosed with stroke

Where?

  • • Oxford - Oxford Centre for Functional MRI of the Brain (FMRIB)

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

Non-invasive brain stimulation (NIBS) has the potential to boost rehabilitation after stroke by creating a 'pro-plastic' environment, where the brain is more adaptable in response to movement (motor) training. However, responses to classical NIBS protocols are highly variable. Movement-related changes in specific brain rhythms have previously been shown to be related to recovery of hand/arm function after a stroke. The investigators propose to use NIBS to target movement-related activity in the beta band (13-30Hz) within the motor cortical regions of the brain. The investigators will use a type of NIBS called transcranial alternating current stimulation (tACS), which uses a sinusoidally-varying electrical current where the stimulation frequency is determined to be relevant to the underlying brain rhythms of interest, and the stimulation timed to coincide with specific phases of the hand/arm movement. The primary aim is to investigate whether beta-tACS improves upper limb movement in stroke survivors.

More detail

Stroke is a leading cause of death and long-term disability worldwide. More than 70% of stroke survivors experience motor impairments, often resulting in difficulties in daily activities, such as walking, reaching and grasping objects. Regaining upper-limb motor function is key to quality of life and for reducing the high annual costs due to stroke. Research indicates that upper-limb motor function recovery depends on the plasticity of neural circuits controlling movement. Beta activity (β, \~13-30 Hz) in the sensorimotor cortex has been associated with brain plasticity and has been proposed to play a pivotal role in human movement and movement disorders. This activity attenuates during movement execution, known as event-related desynchronization (β-ERD), and temporarily increases after the end of movement, known as event-related synchronization (β-ERS). β-ERD and β-ERS are reliably observed during active and passive movement, movement imagination and movement observation. Changes in movement-related β-ERD and β-ERS have been linked to motor learning, and motor dysfunction in neurological conditions, such as stroke. Studies have shown that stroke survivors with upper limb impairments exhibit significantly lower beta activity compared to healthy individuals, and recovery-related improvements in motor function are accompanied by increases in both sensorimotor β-ERD and β-ERS. Therefore, modulation of movement-related beta activity (i.e., β-ERD and β-ERS) holds great promise for promoting motor function after stroke. Non-invasive brain stimulation (NIBS) can be applied during movements to increase plasticity and enhance motor learning and function. However, prior studies have delivered NIBS using a relatively broad approach; modulating general cortical excitability rather than enhancing specific endogenous oscillations in the brain. Transcranial alternating current stimulation (tACS) is a safe and well-tolerated type of NIBS which provides an option for modulating specific frequencies of brain oscillations by delivering a low-intensity sinusoidal electrical current to the brain at a specific frequency. Therefore, this study will deliver beta-tACS to the ipsilesional motor cortex (M1) aiming to modulate sensorimotor beta activity during upper limb movement in stroke survivors. This study will investigate whether functionally timed beta-tACS has the potential to enhance motor recovery, by assessing whether stimulation delivered at the end of the movement improves upper limb movement (accuracy, smoothness and hand function) and increases the modulation of beta activity. Additionally, the investigators will evaluate whether the effectiveness of the stimulation relates to baseline neuroimaging and neurophysiological measures. Identifying correlates of intervention responsiveness will help future studies to target patients who are most likely to benefit.

StrokeUpper Limb Function

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 18 Years and over
  • Who can join: All genders

What the study is looking for

  • ✓Participant is willing and able to give agreement to take part for participation in the study.
  • ✓Aged 18 years or above.
  • ✓Clinical diagnosis of stroke affecting the upper limb, with sufficient ability to perform the upper limb reaching task.
  • ✓At least 3 months post-stroke and discharged from inpatient care.

Who cannot take part

  • ✗Inability to follow task instructions.
  • ✗Other neurological condition affecting movement (e.g. Parkinson's Disease, Multiple Sclerosis).
  • ✗Insufficient verbal and written English to comprehend the study and provide agreement to take part.
See the full criteria
Inclusion Criteria: * Participant is willing and able to give informed consent for participation in the study. * Aged 18 years or above. * Clinical diagnosis of stroke affecting the upper limb, with sufficient ability to perform the upper limb reaching task. * At least 3 months post-stroke and discharged from inpatient care. Exclusion Criteria: * Inability to follow task instructions. * Other neurological condition affecting movement (e.g. Parkinson's Disease, Multiple Sclerosis). * Standard contraindications to non-invasive brain stimulation (TMS, tACS). including (but not limited to) the presence of intracranial metallic or magnetic hardware, seizures, pregnancy, and the presence of a pacemaker or other stimulators/implants. * Insufficient verbal and written English to comprehend the study and provide informed consent.

Where Is This Study? (1 UK site)

Oxford Centre for Functional MRI of the Brain (FMRIB)

Oxford OX3 9DU, United Kingdom

Recruiting
Site contact (verified)

How to Get in Touch

Melanie Fleming, PhD

Sponsor contact

CONTACT

+44 1865 611461 melanie.fleming@ndcn.ox.ac.uk
Data sourced from ClinicalTrials.gov · Last verified: 2024-07